podcast
In this podcast, Hugh Davis, Chief Business Officer at Frontage Laboratories, discusses how bioanalytical laboratories like Frontage keep up with the latest therapies, challenges of a clinical development program design, bioanalytical considerations in developing assays, and the future of this field in the next 5-10 years.
Register to gain access to gated resources.
"*" indicates required fields